G Damaj

Summary

Affiliation: Institut Paoli-Calmettes
Country: France

Publications

  1. ncbi Typical essential thrombocythaemia does not express bcr-abelson fusion transcript
    G Damaj
    Service d Hematologie, Service d Hematologie Biologique, Département de Biostatistique et d Informatique Médicale, and Laboratoire de Cytogénétique, Hopital Necker Enfants Malades, Paris, France
    Br J Haematol 116:812-6. 2002
  2. ncbi Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy
    G Damaj
    Department of Clinical Hematology, Hopital Necker Enfants Malades, Paris, France
    Eur J Haematol 68:233-5. 2002
  3. ncbi Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review
    G Damaj
    Hopital Necker Enfants Malades, Paris, France
    Ann Oncol 14:623-9. 2003
  4. ncbi The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients
    F Lefrere
    Service de Biothérapies, Hopital Necker, AP HP, Paris, France
    Bone Marrow Transplant 37:725-9. 2006
  5. ncbi Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia
    V Asnafi
    Laboratoire d Hematologie, AP HP Necker, Paris, France
    Leukemia 20:793-9. 2006
  6. ncbi Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation
    D McNeel
    Hopital Necker Enfants Malades, Paris, France
    Transplantation 74:1797-800. 2002
  7. ncbi [Is oral chemotherapy an alternative to IV chemotherapy in aged patients?]
    A C Braud
    Service d Oncologie Medicale, Institut Paoli Calmettes, 232, boulevard Sainte Marguerite, 13009 Marseille, France
    Pathol Biol (Paris) 53:52-4. 2005
  8. ncbi Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation
    M Mohty
    Unite de Transplantation et de Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France
    Bone Marrow Transplant 34:77-84. 2004
  9. ncbi Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study
    F Lefrere
    Service d Hématologie Adultes, Hopital Necker, Paris, France
    Leukemia 16:587-93. 2002
  10. ncbi Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases
    P Guilpain
    Department of Clinical Hematology, Hopital Necker Enfants Malades, Assistance Publique Hopitaux de Paris, Universite Paris V, Paris, France
    Respiration 76:295-302. 2008

Collaborators

Detail Information

Publications16

  1. ncbi Typical essential thrombocythaemia does not express bcr-abelson fusion transcript
    G Damaj
    Service d Hematologie, Service d Hematologie Biologique, Département de Biostatistique et d Informatique Médicale, and Laboratoire de Cytogénétique, Hopital Necker Enfants Malades, Paris, France
    Br J Haematol 116:812-6. 2002
    ..A prospective study is warranted in order to define better the clinical and biological characteristics of bcr-abl-expressing ET...
  2. ncbi Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy
    G Damaj
    Department of Clinical Hematology, Hopital Necker Enfants Malades, Paris, France
    Eur J Haematol 68:233-5. 2002
    ..We report here a case of remission of myelodysplastic syndrome with myelofibrosis in transformation after danazol therapy in a 72-yr-old man. The role of danazol in remission induction is briefly discussed...
  3. ncbi Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review
    G Damaj
    Hopital Necker Enfants Malades, Paris, France
    Ann Oncol 14:623-9. 2003
    ..To describe better the clinical, biological, endoscopic and pathological presentations, as well as the outcome, of primary follicular lymphoma (FL) of the gastrointestinal (GI) tract...
  4. ncbi The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients
    F Lefrere
    Service de Biothérapies, Hopital Necker, AP HP, Paris, France
    Bone Marrow Transplant 37:725-9. 2006
    ....
  5. ncbi Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia
    V Asnafi
    Laboratoire d Hematologie, AP HP Necker, Paris, France
    Leukemia 20:793-9. 2006
    ..These data should facilitate risk-adapted post-transplant immunosuppression and/or tyrosine kinase inhibitor therapy based on an early evaluation of MRD...
  6. ncbi Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation
    D McNeel
    Hopital Necker Enfants Malades, Paris, France
    Transplantation 74:1797-800. 2002
    ..These two patients were treated by glucocorticoids with resolution of the hypereosinophilia and the symptoms of GVHD. The authors briefly discuss the possible mechanisms of this hypereosinophilia with respect to aGVHD...
  7. ncbi [Is oral chemotherapy an alternative to IV chemotherapy in aged patients?]
    A C Braud
    Service d Oncologie Medicale, Institut Paoli Calmettes, 232, boulevard Sainte Marguerite, 13009 Marseille, France
    Pathol Biol (Paris) 53:52-4. 2005
  8. ncbi Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation
    M Mohty
    Unite de Transplantation et de Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France
    Bone Marrow Transplant 34:77-84. 2004
    ..006 for PFS and P=0.01 for OS). Collectively, these data demonstrate that RIC allo-SCT can mediate a potentially curative graft-versus-myeloma effect with an acceptable incidence of toxicity and TRM...
  9. ncbi Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study
    F Lefrere
    Service d Hématologie Adultes, Hopital Necker, Paris, France
    Leukemia 16:587-93. 2002
    ....
  10. ncbi Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases
    P Guilpain
    Department of Clinical Hematology, Hopital Necker Enfants Malades, Assistance Publique Hopitaux de Paris, Universite Paris V, Paris, France
    Respiration 76:295-302. 2008
    ..Some studies have suggested an association between PH and myeloproliferative diseases (MPD)...
  11. doi Tyrosine kinase inhibitors and solid tumours: case report and review of the literature
    F Roszkiewicz
    Service d Hematologie, Centre Hospitalier Universitaire, Amiens, France
    Pharmacology 84:38-41. 2009
    ..Imatinib has remarkably improved the prognosis of patients with CML. Monitoring of the long-term safety profile of TKIs is essential due to the prolonged survival of these patients...
  12. ncbi Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
    S Depil
    Service des Maladies du Sang, CHRU de Lille, France
    Bone Marrow Transplant 33:531-4. 2004
    ..Eight patients died of disease progression. Although DLI alone seems to be effective in a small number of patients with MDS, other treatment strategies, including prior debulking chemotherapy, deserve investigation...
  13. ncbi First-line autologous stem cell transplantation in primary CNS lymphoma
    M Brevet
    Centre Hospitalier Universitaire Amiens, Service des Maladies du Sang, rue Laennec, 80054 Amiens cedex 01, France
    Eur J Haematol 75:288-92. 2005
    ..These results are fairly encouraging. Other studies with greater numbers of patients and longer follow-up are needed to confirm this study...
  14. ncbi Thalidomide therapy induces response in relapsed mantle cell lymphoma
    G Damaj
    Leukemia 17:1914-5. 2003
  15. ncbi Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts
    V Ribrag
    Institut Gustave Roussy, Villejuif, France
    Leukemia 17:319-22. 2003
    ..Thus CPT-11 has an interesting activity in MDS with excess of blasts; toxicity is easily managed and most patients can be treated in the out-clinic setting. These results suggest that further evaluation of CPT-11 in MDS is warranted...
  16. ncbi [Haematopoietic stem cell transplantation in the treatment of autoimmune diseases]
    M Mahevas
    Service de Medecine Interne, Hopital Nord, CHU d Amiens, Place Victor Pauchet, 80054 Amiens Cedex 1, France
    Rev Med Interne 29:115-21. 2008
    ..These new therapeutic have been used in systemic sclerosis (scleroderma), multiple sclerosis, rheumatoid arthritis, juvenile idiopathic arthritis and systemic lupus erythematosus...